Multicyclic bis-amide MMP inhibitors

Details for Australian Patent Application No. 2005326659 (hide)

Owner Alantos Pharmaceuticals, Inc.

Inventors Powers, Timothy; Wu, Xinyuan; Kiely, Andrew; Richter, Frank; Sucholeiki, Irving; Van Veldhuizen, Joshua; Steeneck, Christoph; Hochgurtel, Matthias; Gege, Christian; Taveras, Arthur G.; Biesinger, Ralf; Schneider, Mathias; Bluhm, Harald; Gallagher, Brian M. Jr.; Deng, Hongbo; Dodd, Rory

Agent Fisher Adams Kelly

Pub. Number AU-A-2005326659

PCT Pub. Number WO2006/083454

Priority 60/706,267 08.08.05 US; 60/640,795 31.12.04 US

Filing date 31 December 2005

Wipo publication date 10 August 2006

International Classifications

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/083454 Priority application(s): WO2006/083454

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005326660-Targeted delivery of Botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions

2005326656-Heat exchanger with perforated plate in header